| Original language | English |
|---|---|
| Journal | Frontiers in Immunology |
| Volume | 9 |
| Issue number | NOV |
| DOIs | |
| Publication status | Published - 2018 |
Cite this
Morandi, F., Horenstein, A. L., Costa, F., Giuliani, N., Pistoia, V., & Malavasi, F. (2018). CD38: A target for immunotherapeutic approaches in multiple myeloma. Frontiers in Immunology, 9(NOV). https://doi.org/10.3389/fimmu.2018.02722
CD38: A target for immunotherapeutic approaches in multiple myeloma. / Morandi, F.; Horenstein, A.L.; Costa, F.; Giuliani, N.; Pistoia, V.; Malavasi, F.
In: Frontiers in Immunology, Vol. 9, No. NOV, 2018.Research output: Contribution to journal › Article
Morandi, F, Horenstein, AL, Costa, F, Giuliani, N, Pistoia, V & Malavasi, F 2018, 'CD38: A target for immunotherapeutic approaches in multiple myeloma', Frontiers in Immunology, vol. 9, no. NOV. https://doi.org/10.3389/fimmu.2018.02722
Morandi F, Horenstein AL, Costa F, Giuliani N, Pistoia V, Malavasi F. CD38: A target for immunotherapeutic approaches in multiple myeloma. Frontiers in Immunology. 2018;9(NOV). https://doi.org/10.3389/fimmu.2018.02722
@article{d7b51271818042088c3888dc9fa5e2d3,
title = "CD38: A target for immunotherapeutic approaches in multiple myeloma",
author = "F. Morandi and A.L. Horenstein and F. Costa and N. Giuliani and V. Pistoia and F. Malavasi",
note = "Export Date: 30 January 2019",
year = "2018",
doi = "10.3389/fimmu.2018.02722",
language = "English",
volume = "9",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S.A.",
number = "NOV",
}
TY - JOUR
T1 - CD38: A target for immunotherapeutic approaches in multiple myeloma
AU - Morandi, F.
AU - Horenstein, A.L.
AU - Costa, F.
AU - Giuliani, N.
AU - Pistoia, V.
AU - Malavasi, F.
N1 - Export Date: 30 January 2019
PY - 2018
Y1 - 2018
U2 - 10.3389/fimmu.2018.02722
DO - 10.3389/fimmu.2018.02722
M3 - Article
VL - 9
JO - Frontiers in Immunology
JF - Frontiers in Immunology
SN - 1664-3224
IS - NOV
ER -